🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/07/2019 | 76,93 | 78,92 | 76,87 | 77,60 | +0,94% | 2,66% | 578.800 |
| 25/07/2019 | 76,88 | 78,40 | 76,72 | 76,88 | +0,22% | 2,19% | 550.900 |
| 24/07/2019 | 74,94 | 76,83 | 74,47 | 76,71 | +2,36% | 3,15% | 475.900 |
| 23/07/2019 | 75,00 | 75,26 | 74,31 | 74,94 | +0,12% | 1,27% | 328.400 |
| 22/07/2019 | 75,50 | 75,66 | 74,65 | 74,85 | -0,62% | 1,34% | 359.400 |
| 19/07/2019 | 76,39 | 77,02 | 75,14 | 75,32 | -1,22% | 2,46% | 930.300 |
| 18/07/2019 | 75,92 | 76,98 | 75,66 | 76,25 | +0,16% | 1,74% | 468.200 |
| 17/07/2019 | 76,20 | 76,94 | 75,45 | 76,13 | +0,28% | 1,96% | 347.700 |
| 16/07/2019 | 76,26 | 76,86 | 75,55 | 75,92 | -0,34% | 1,72% | 402.600 |
| 15/07/2019 | 76,56 | 76,56 | 75,31 | 76,18 | -0,39% | 1,63% | 324.000 |
| 12/07/2019 | 77,27 | 78,30 | 76,06 | 76,48 | -1,30% | 2,90% | 321.500 |
| 11/07/2019 | 79,04 | 79,22 | 77,27 | 77,49 | -2,07% | 2,47% | 536.700 |
| 10/07/2019 | 80,62 | 80,62 | 78,21 | 79,13 | -1,16% | 2,99% | 511.900 |
| 09/07/2019 | 78,17 | 81,22 | 77,96 | 80,06 | +2,50% | 4,17% | 502.200 |
| 08/07/2019 | 79,73 | 79,97 | 77,31 | 78,11 | -2,37% | 3,34% | 848.500 |
| 05/07/2019 | 81,61 | 82,11 | 79,69 | 80,01 | -2,32% | 2,97% | 492.600 |
| 03/07/2019 | 82,54 | 82,54 | 80,33 | 81,91 | -1,02% | 2,68% | 824.500 |
| 02/07/2019 | 82,67 | 82,78 | 81,18 | 82,75 | +0,85% | 1,94% | 786.100 |
| 01/07/2019 | 82,55 | 82,75 | 81,38 | 82,05 | +5,11% | 1,66% | 838.000 |
| 28/06/2019 | 77,09 | 78,13 | 77,02 | 78,06 | +1,36% | 1,44% | 676.600 |
| 27/06/2019 | 76,11 | 78,13 | 76,11 | 77,01 | +0,85% | 2,65% | 534.500 |
| 26/06/2019 | 77,72 | 78,31 | 75,96 | 76,36 | -1,16% | 3,02% | 524.100 |
| 25/06/2019 | 76,48 | 79,03 | 75,85 | 77,26 | +1,58% | 4,16% | 906.500 |
| 24/06/2019 | 77,44 | 77,64 | 75,72 | 76,06 | -1,87% | 2,48% | 680.400 |
| 21/06/2019 | 77,66 | 78,75 | 76,52 | 77,51 | -0,55% | 2,87% | 768.100 |
| 20/06/2019 | 79,10 | 80,42 | 77,43 | 77,94 | -0,84% | 3,78% | 649.400 |
| 19/06/2019 | 78,41 | 78,89 | 76,96 | 78,60 | +0,00% | 2,46% | 811.400 |
| 18/06/2019 | 79,09 | 81,10 | 78,40 | 78,60 | +0,03% | 3,41% | 676.200 |
| 17/06/2019 | 78,66 | 79,92 | 78,24 | 78,58 | +0,45% | 2,14% | 688.300 |
| 14/06/2019 | 80,83 | 80,84 | 77,78 | 78,23 | -3,50% | 3,79% | 829.000 |